TMCnet News
AiCure's strategy of providing data for life sciences reinforced by record economic momentumNEW YORK, Jan. 14, 2020 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence (AI) companies, announced significant 2019 company momentum, growing revenue by over 65% from the prior year. In September 2019, AiCure announced a $24.5 million Series C funding, round bringing total capital raised to date at over $50 million. The company set a record pace of new customer acquisition with the addition of 13 new pharmaceutical and biotechnology companies. AiCure doubled the number of deployments contracted and supported clinical trial programs within 16 new countries. AiCure amplified a preexisting relationship with Syneos Health® (Nasdaq:SYNH), announcing Syneos as the first mover participant in its AiCure Partnerships for Excellence (AiPEX™) program – a novel strategic contract research organization (CRO) partnership to drive faster, smarter trials to optimize patient engagement. AiCure increased its patent portfolio to 67 issued and allowed patents in the U.S. and worldwide, with over 110 patents filed. "We are defining a new gold standard in life science data tools, our company's dramatic growth is evident, and we will continue to set the bar high as we deliver operational and clinical intelligence with our partners," said Adam Hanina, chief executive officer of AiCure. "AiCure is well-positioned as we enter 2020 to continue to pursue our mission of establishing the link between patients, disease and treatment." As part of this tremendous growth, AiCure has achieved several corporate, artificial intelligence and client milestones, including: <>Corporate Momentum
Artificial Intelligence and Platform Milestones
Client Milestones
About AiCure Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors, AiCure has more than 110 patents filed and works with global clients in over 30 countries. AiCure is globally recognized and a recipient of the Scrip Award, AI 100 and Digital Health 150. For more information, please visit www.aicure.com and follow our progress on LinkedIn and on Twitter @AiCure. Contact information: View original content to download multimedia:http://www.prnewswire.com/news-releases/aicures-strategy-of-providing-data-for-life-sciences-reinforced-by-record-economic-momentum-300986570.html SOURCE AiCure |